LawrenceD.KaplanMD
Oncology • San Francisco, CAHematologic Oncology
Clinical Professor of Medicine, UCSF
Dr. Kaplan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2421Fax+1 415-353-2467
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1983 - 1985
Boston University Medical CenterResidency, Internal Medicine, 1980 - 1983
David Geffen School of Medicine at UCLAClass of 1980
Certifications & Licensure
CA State Medical License 1983 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma Start of enrollment: 1999 Jan 01
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Start of enrollment: 1999 Jan 01
- Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 44 citationsNCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022.William G Wierda, Jennifer Brown, Jeremy S Abramson, Farrukh Awan, Syed F Bilgrami
Journal of the National Comprehensive Cancer Network. 2022-06-01 - 60 citationsHuman herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphomaLawrence D. Kaplan
Hematology. American Society of Hematology. Education Program. 2013-12-06 - 320 citationsIntensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)James L. Rubenstein, Eric D. Hsi, Jeffrey L. Johnson, Sin-Ho Jung, Megan O. Nakashima
Journal of Clinical Oncology. 2013-04-08
Abstracts/Posters
- Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...Lawrence D Kaplan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatm...Lawrence D Kaplan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Phase 1b Dose Escalation Trial of Carfilzomib in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin LymphomaLawrence D Kaplan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Press Mentions
OncLive® Presents State of the Science Summit™: Hematologic MalignanciesDecember 5th, 2017
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
